Innate Pharma News, Innate Pharma Quote, IPH Quote

Innate Pharma (OB:IPH) Delayed: 0.04 --0 (-0%)

Prev. Close

$0.04

Open

$0.04

52 Wk High

$0.04

52 Wk Low

$0.04

Day High

$0.04

Day Low

$0.04

P/E

N/A

EPS

$0.00

Volume

71,303

Friends, Peers and Foes (?): IPHA, IPHYF, AZN, SNY SAN (more...)

Apr 15, 2024 06:25 AM Form 6-K Innate Pharma SA For: Apr 15
Apr 15, 2024 06:18 AM Form 6-K Innate Pharma SA For: Apr 15
Apr 15, 2024 01:01 AM Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 23, 2024
Apr 15, 2024 01:01 AM Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients
Apr 10, 2024 06:52 AM Form 6-K Innate Pharma SA For: Apr 10
Apr 10, 2024 01:01 AM Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Apr 9, 2024 01:00 AM Innate Pharma Announces Its Participation in Upcoming Investor Conference
Apr 5, 2024 03:34 AM Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Apr 4, 2024 08:09 AM Form 20-F Innate Pharma SA For: Dec 31
Mar 21, 2024 09:21 AM Form 6-K Innate Pharma SA For: Mar 21

Entities mentioned with IPH